Drug discovery platform
The platform is designed to identify treatments for diseases caused by DNA packaging defects, including several hard-to-treat cancers.
Source: LinkedIn company description · Retrieved October 13, 2026
TippingPoint Biosciences is a San Francisco-based therapeutic company focused on diseases with high unmet needs.
The company’s drug discovery platform identifies potential treatments for diseases caused by defects in DNA packaging, including hard-to-treat cancers. Its platform recreates cancer-driving chromatin states in a controlled, cell-free environment.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The platform is designed to identify treatments for diseases caused by DNA packaging defects, including several hard-to-treat cancers.
Source: LinkedIn company description · Retrieved October 13, 2026
The company is developing a new class of drugs targeting genome packaging states known to cause disease.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.